tiprankstipranks
Protagonist Therapeutics (DE:PGF)
BERLIN:PGF
Germany Market
PGF
Protagonist Therapeutics
RESEARCH TOOLSreports

Protagonist Therapeutics (PGF) Ratios

1 Followers

Protagonist Therapeutics Ratios

DE:PGF's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, DE:PGF's free cash flow was decreased by $ and operating cash flow was $0.77. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 21.71 12.71 12.48 16.71 7.80
Quick Ratio
 21.71 12.71 12.48 16.71 7.80
Cash Ratio
 11.30 2.83 2.05 8.78 4.03
Solvency Ratio
 1.91 -2.34 3.98 -3.56 -3.84
Operating Cash Flow Ratio
 3.53 1.27 3.89 -3.30 -3.47
Short-Term Operating Cash Flow Coverage
 54.76 25.26 361.08 0.00 0.00
Net Current Asset Value
$ 763.15M$ 522.39M$ 522.21M$ 334.30M$ 210.76M
Leverage Ratios
Debt-to-Assets Ratio
 0.01 0.02 0.01 <0.01 0.01
Debt-to-Equity Ratio
 0.01 0.02 0.02 <0.01 0.02
Debt-to-Capital Ratio
 0.01 0.02 0.02 <0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.05 1.09 1.10 1.06 1.15
Debt Service Coverage Ratio
 35.08 -56.47 541.20 0.00 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 <0.01 0.00 0.00
Interest Debt Per Share
 0.14 0.16 0.18 0.02 0.07
Net Debt to EBITDA
 -4.81 0.92 -0.31 2.05 0.95
Profitability Margins
Gross Profit Margin
99.86%97.34%100.00%100.00%100.00%
EBIT Margin
29.91%-281.01%64.32%-156.09%-494.24%
EBITDA Margin
30.31%-278.35%64.51%-150.57%-481.56%
Operating Profit Margin
20.69%-343.63%58.20%-156.09%-494.24%
Pretax Profit Margin
29.91%-281.01%64.32%-131.59%-479.26%
Net Profit Margin
29.40%-282.83%63.34%-131.59%-479.26%
Continuous Operations Profit Margin
29.40%-282.83%63.34%-131.59%-479.26%
Net Income Per EBT
98.31%100.65%98.49%100.00%100.00%
EBT Per EBIT
144.56%81.78%110.51%84.31%96.97%
Return on Assets (ROA)
9.36%-19.43%36.95%-22.06%-51.38%
Return on Equity (ROE)
12.03%-21.17%40.75%-23.45%-59.09%
Return on Capital Employed (ROCE)
6.88%-25.32%36.26%-27.82%-60.61%
Return on Invested Capital (ROIC)
6.74%-25.23%35.69%-27.72%-59.92%
Return on Tangible Assets
9.36%-19.43%36.95%-22.06%-51.38%
Earnings Yield
0.86%-2.34%11.58%-6.07%-23.81%
Efficiency Ratios
Receivables Turnover
 21.02 10.23 2.58 5.81 511.17
Payables Turnover
 0.12 0.23 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 81.59 3.94 34.46 27.92 5.75
Asset Turnover
 0.32 0.07 0.58 0.17 0.11
Working Capital Turnover Ratio
 0.42 0.09 0.99 0.22 0.10
Cash Conversion Cycle
 -3.08K -1.56K 141.56 62.85 0.71
Days of Sales Outstanding
 17.37 35.66 141.56 62.85 0.71
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 3.10K 1.59K 0.00 0.00 0.00
Operating Cycle
 17.37 35.66 141.56 62.85 0.71
Cash Flow Ratios
Operating Cash Flow Per Share
 1.99 0.91 2.99 -1.24 -2.20
Free Cash Flow Per Share
 2.00 0.88 2.97 -1.25 -2.22
CapEx Per Share
 0.01 0.03 0.02 0.01 0.02
Free Cash Flow to Operating Cash Flow
 1.01 0.97 0.99 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
 134.56 36.27 135.91 -115.33 -136.02
Capital Expenditure Coverage Ratio
 134.56 36.27 135.91 -115.33 -136.02
Operating Cash Flow Coverage Ratio
 14.24 5.59 16.95 -61.56 -29.58
Operating Cash Flow to Sales Ratio
 0.47 1.25 0.42 -1.17 -4.07
Free Cash Flow Yield
1.41%1.01%7.69%-5.44%-20.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 119.63 -42.60 8.64 -16.49 -4.20
Price-to-Sales (P/S) Ratio
 33.23 120.66 5.47 21.69 20.13
Price-to-Book (P/B) Ratio
 11.42 9.03 3.52 3.87 2.48
Price-to-Free Cash Flow (P/FCF) Ratio
 70.90 99.01 13.00 -18.37 -4.91
Price-to-Operating Cash Flow Ratio
 73.23 96.28 12.91 -18.53 -4.95
Price-to-Earnings Growth (PEG) Ratio
 -0.14 0.29 -0.02 0.37 0.86
Price-to-Fair Value
 11.42 9.03 3.52 3.87 2.48
Enterprise Value Multiple
 104.82 -42.43 8.17 -12.35 -3.23
Enterprise Value
 8.96B 5.43B 2.29B 1.12B 412.96M
EV to EBITDA
 104.82 -42.43 8.17 -12.35 -3.23
EV to Sales
 31.78 118.10 5.27 18.60 15.54
EV to Free Cash Flow
 67.79 96.90 12.53 -15.75 -3.79
EV to Operating Cash Flow
 68.30 94.23 12.44 -15.89 -3.82
Tangible Book Value Per Share
 12.76 9.67 10.97 5.93 4.40
Shareholders’ Equity Per Share
 12.76 9.67 10.97 5.93 4.40
Tax and Other Ratios
Effective Tax Rate
 0.02 >-0.01 0.02 0.00 0.00
Revenue Per Share
 4.28 0.72 7.06 1.06 0.54
Net Income Per Share
 1.26 -2.05 4.47 -1.39 -2.60
Tax Burden
 0.98 1.01 0.98 1.00 1.00
Interest Burden
 1.00 1.00 1.00 0.84 0.97
Research & Development to Revenue
 0.62 3.46 0.32 2.00 4.75
SG&A to Revenue
 0.17 0.97 0.10 0.56 1.19
Stock-Based Compensation to Revenue
 0.18 1.00 0.09 0.49 0.91
Income Quality
 0.62 -0.44 0.67 0.89 0.85
Currency in USD